Bio-experienced psoriasis patients treated with anti-interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients.
Autor: | Margiotta, Flavia Manzo, Michelucci, Alessandra, Panduri, Salvatore, Angeloni, Laura, Fidanzi, Cristian, Granieri, Giammarco, Morganti, Riccardo, Romanelli, Marco, Dini, Valentina |
---|---|
Zdroj: | JEADV Clinical Practice; Mar2024, Vol. 3 Issue 1, p65-75, 11p |
Databáze: | Complementary Index |
Externí odkaz: |